dual glp-1/gip agonist GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Semaglutide vs. Tirzepatide: Which GLP-1
Description
Research shows patients typically regain 50-80% of lost weight within 6-12 months after discontinuing treatment
August 11, 2023
Check with your healthcare provider to see if they are right for you
GLP-1 drugs, however, seem more like a lanyard that holds your house keys, your car keys, your friends backup keys, your CVS rewards card, your work fob, and a mini Swiss army knife that has little tools on it that youve never actually figured out how to use
Smith, C
